EMMA and ISA
Device Devices
General payments
$557,754
Research payments
$4,040,110
Through program year 2025, $557,754 in general payments and $4,040,110 in research payments were reported against EMMA and ISA (Devices).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
8 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $6,431 | 56 |
| 2025 | Research | $484,054 | 90 |
| 2024 | General | $566 | 4 |
| 2024 | Research | $1,411,957 | 371 |
| 2020 | General | $280,484 | 164 |
| 2020 | Research | $841,602 | 195 |
| 2019 | General | $270,272 | 248 |
| 2019 | Research | $1,302,497 | 316 |
Breakdown
Each share is of general payments naming this product in 2025.
Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2025 where a state was reported.
Records
472 general · 972 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.